Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04114903

Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity

Sponsor: University of Colorado, Boulder

View on ClinicalTrials.gov

Summary

This study tests the effects of cannabinoid levels in blood on inflammation and insulin sensitivity both acutely and chronically in individuals across the weight spectrum. To that end, the study employs two observational designs: 1) A study of acute effects with intermittent cannabis users and 2) A study in which current cannabis users will select one of three cannabis strains for four weeks and are compared to a matched control group who do not use cannabis to study chronic effects. Blood levels of THC and CBD, inflammatory biomarkers, and insulin resistance will be measured in both studies.

Key Details

Gender

All

Age Range

21 Years - 40 Years

Study Type

OBSERVATIONAL

Enrollment

233

Start Date

2019-11-08

Completion Date

2024-12-01

Last Updated

2026-08-06

Healthy Volunteers

Not specified

Interventions

OTHER

Study A: Single use of cannabis flower product

Participants are asked to purchase and use one of three cannabis flower strains with differing levels of THC and CBD: 1) CBD (\~14% CBD/0% THC), 2) THC (\~14% THC/0% CBD), or 3) THC+CBD (\~7% THC/7% CBD).

OTHER

Study B: Ad libitum cannabis use for four weeks or no cannabis use

Participants choose whether to use a cannabis flower product ad libitum for four weeks or to not use cannabis for four weeks. Participants who choose to use cannabis are asked to purchase and use one of three cannabis flower strains with differing levels of THC and CBD: 1) CBD (\~14% CBD/0% THC), 2) THC (\~14% THC/0% CBD), or 3) THC+CBD (\~7% THC/7% CBD).

Locations (1)

Center for Innovation and Creativity

Boulder, Colorado, United States